Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4065)
All Articles published online
|
Jun 7, 2009 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pereira RM, Santos RASD, Dias FLDC, Teixeira MM, Silva ACSE. Renin-angiotensin system in the pathogenesis of liver fibrosis. World J Gastroenterol 2009; 15(21): 2579-2586 [PMID: 19496186 DOI: 10.3748/wjg.15.2579] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i21/2579.htm |
| Number | Citing Articles |
| 1 |
Simone Moreira de Macêdo, Talita Antunes Guimarães, John David Feltenberger, Sérgio Henrique Sousa Santos. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases. Peptides 2014; 62: 189 doi: 10.1016/j.peptides.2014.10.005
|
| 2 |
Hsi-Tien Wu, Ya-Wen Chuang, Cheng-Pu Huang, Ming-Huang Chang. Loss of angiotensin converting enzyme II (ACE2) accelerates the development of liver injury induced by thioacetamide. Experimental Animals 2018; 67(1): 41 doi: 10.1538/expanim.17-0053
|
| 3 |
George B Goh, Mangesh R Pagadala, Jaividhya Dasarathy, Aynur Unalp‐Arida, Ruth Sargent, Carol Hawkins, Achuthan Sourianarayanane, Amer Khiyami, Lisa Yerian, Rish Pai, Arthur J McCullough, Srinivasan Dasarathy. Renin‐angiotensin system and fibrosis in non‐alcoholic fatty liver disease. Liver International 2015; 35(3): 979 doi: 10.1111/liv.12611
|
| 4 |
Mohammad AlQudah, Taben M. Hale, Michael P. Czubryt. Targeting the renin-angiotensin-aldosterone system in fibrosis. Matrix Biology 2020; : 92 doi: 10.1016/j.matbio.2020.04.005
|
| 5 |
Fredrik Åberg, Katri Kantojärvi, Ville Männistö, Anna But, Veikko Salomaa, Teemu Niiranen, Martti Färkkilä, Panu Luukkonen, Satu Männistö, Annamari Lundqvist, Markus Perola, Antti Jula. Association between arterial hypertension and liver outcomes using polygenic risk scores: a population-based study. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-20084-z
|
| 6 |
Ralf Bahde, Linus Kebschull, Sandra Stöppeler, Andree Zibert, Ramsi Siaj, Jens P Hölzen, Evgeny Minin, Hartmut H.-J. Schmidt, Hans-Ullrich Spiegel, Daniel Palmes. Role of angiotensin-1 receptor blockade in cirrhotic liver resection. Liver International 2011; 31(5): 642 doi: 10.1111/j.1478-3231.2011.02493.x
|
| 7 |
Iván Pérez-Díaz, Carolina Guzmán, Jesús Alberto Olivares-Reyes, Teresa Ramírez, Gabriela Gutierréz-Reyes, Marcia Hiriart, Guillermo Robles-Díaz. Evidence of an Intracellular Angiotensin-Generating System and Non-AT1, Non-AT2 Binding Site in a Human Pancreatic Cell Line. Pancreas 2011; 40(5): 701 doi: 10.1097/MPA.0b013e318215a891
|
| 8 |
Yuni Eka Anggraini, Niken Trisnowati, Ronny Martien, Retno Danarti. A randomised clinical trial study assessing the efficacy of 5% losartan potassium loaded in ethosomal gel to treat human keloids: a trial protocol. Trials 2024; 25(1) doi: 10.1186/s13063-023-07880-2
|
| 9 |
M Kamruzzman Munshi, Mohammad N Uddin, Shannon S Glaser. The role of the renin–angiotensin system in liver fibrosis. Experimental Biology and Medicine 2011; 236(5): 557 doi: 10.1258/ebm.2011.010375
|
| 10 |
Enrique Brandan, Jaime Gutierrez. Role of proteoglycans in the regulation of the skeletal muscle fibrotic response. The FEBS Journal 2013; 280(17): 4109 doi: 10.1111/febs.12278
|
| 11 |
Blanca Martínez Soriano, Antonio Güemes, Guillermo Pola, Azucena Gonzalo, Pilar Palacios Gasós, Ana C. Navarro, Roberto Martínez-Beamonte, Jesús Osada, José J. García. Effect of Melatonin as an Antioxidant Drug to Reverse Hepatic Steatosis: Experimental Model. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/7315253
|
| 12 |
V.M. Eulenberg, J.A. Lidbury. Hepatic Fibrosis in Dogs. Journal of Veterinary Internal Medicine 2018; 32(1): 26 doi: 10.1111/jvim.14891
|
| 13 |
Seth J. Corey, Jyoti Jha, Elizabeth A. McCart, William B. Rittase, Jeffy George, Joseph J. Mattapallil, Hrishikesh Mehta, Mungunsukh Ognoon, Michelle A. Bylicky, Thomas A. Summers, Regina M. Day. Captopril mitigates splenomegaly and myelofibrosis in the Gata1low murine model of myelofibrosis. Journal of Cellular and Molecular Medicine 2018; 22(9): 4274 doi: 10.1111/jcmm.13710
|
| 14 |
Sundar Raman Subramanian, Ettayapuram Ramaprasad Azhagiya Singam, Michael Berinski, Venkatesan Subramanian, Rebecca C. Wade. Identification of an Electrostatic Ruler Motif for Sequence-Specific Binding of Collagenase to Collagen. The Journal of Physical Chemistry B 2016; 120(33): 8580 doi: 10.1021/acs.jpcb.6b02573
|
| 15 |
Cheng Yan, Yandie Niu, Liukai Ma, Lifang Tian, Jiahao Ma. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03630-1
|
| 16 |
María José Acuña, Patrizia Pessina, Hugo Olguin, Daniel Cabrera, Carlos P. Vio, Michael Bader, Pura Muñoz-Canoves, Robson A. Santos, Claudio Cabello-Verrugio, Enrique Brandan. Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling. Human Molecular Genetics 2014; 23(5): 1237 doi: 10.1093/hmg/ddt514
|
| 17 |
Jess Hoy, Hiroko Nishimura, Theodore Mehalic, Eishin Yaoita, R. Ariel Gomez, Robert Paxton, Maria Luisa S. Sequeira-Lopez. Ontogeny of renin gene expression in the chicken, Gallus gallus. General and Comparative Endocrinology 2020; 296: 113533 doi: 10.1016/j.ygcen.2020.113533
|
| 18 |
Carmine Savoia, Dylan Burger, Nobu Nishigaki, Augusto Montezano, Rhian M. Touyz. Angiotensin II and the vascular phenotype in hypertension. Expert Reviews in Molecular Medicine 2011; 13 doi: 10.1017/S1462399411001815
|
| 19 |
Jung Gyu Park, Jong Soo Mok, Young In Han, Tae Sub Park, Keon Wook Kang, Cheol Soo Choi, Hee Dong Park, Joonghoon Park. Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-40322-1
|
| 20 |
Reju George Thomas, Myeong Ju Moon, Jo Heon Kim, Jae Hyuk Lee, Yong Yeon Jeong, Hélder A. Santos. Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model. PLOS ONE 2015; 10(12): e0145512 doi: 10.1371/journal.pone.0145512
|
| 21 |
E. Matthew Morris, Justin A. Fletcher, John P. Thyfault, R. Scott Rector. The role of angiotensin II in nonalcoholic steatohepatitis. Molecular and Cellular Endocrinology 2013; 378(1-2): 29 doi: 10.1016/j.mce.2012.04.013
|
| 22 |
Zainab Mastoor, Yolanda Diz-Chaves, Lucas C. González-Matías, Federico Mallo. Renin–Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins. Metabolites 2022; 12(5): 411 doi: 10.3390/metabo12050411
|
| 23 |
Yoshihide Asano, Shinichi Sato. Animal Models of Scleroderma: Current State and Recent Development. Current Rheumatology Reports 2013; 15(12) doi: 10.1007/s11926-013-0382-7
|
| 24 |
Ralf Bahde, Sorabh Kapoor. Antifibrotic effect of angiotensin blockers in hypertensive hepatitis C patients. Liver International 2009; 29(10): 1597 doi: 10.1111/j.1478-3231.2009.02115.x
|
| 25 |
Lingfeng Pan, Haiyan Qin, Caihong Li, Liehao Yang, Mingxi Li, Jiao Kong, Guang Zhang, Lianbo Zhang. Safety and efficacy of botulinum toxin type A in preventing and treating scars in animal models: A systematic review and meta‐analysis. International Wound Journal 2022; 19(4): 774 doi: 10.1111/iwj.13673
|
| 26 |
Luis Téllez, Audrey Payancé, Eric Tjwa, María Jesús del Cerro, Lars Idorn, Stanislav Ovroutski, Ruth De Bruyne, Henkjan J. Verkade, Fabrizio De Rita, Charlotte de Lange, Annalisa Angelini, Valérie Paradis, Pierre Emmanuel Rautou, Juan Carlos García-Pagán. EASL-ERN position paper on liver involvement in patients with Fontan-type circulation. Journal of Hepatology 2023; 79(5): 1270 doi: 10.1016/j.jhep.2023.07.013
|
| 27 |
Moira B. Hilscher, Michael L. Wells, Sudhakar K. Venkatesh, Frank Cetta, Patrick S. Kamath. Fontan‐associated liver disease. Hepatology 2022; 75(5): 1300 doi: 10.1002/hep.32406
|
| 28 |
Lidija Orlic, Ivana Mikolasevic, Vesna Lukenda, Kata Anic, Ita Jelic, Sanjin Racki. Nonalcoholic fatty liver disease and the renin-angiotensin system blockers in the patients with chronic kidney disease. Wiener klinische Wochenschrift 2015; 127(9-10): 355 doi: 10.1007/s00508-014-0661-y
|
| 29 |
Ehab Farag, Kamal Maheshwari, Joseph Morgan, Wael Ali Sakr Esa, D. John Doyle. An Update of the Role of Renin Angiotensin in Cardiovascular Homeostasis. Anesthesia & Analgesia 2015; 120(2): 275 doi: 10.1213/ANE.0000000000000528
|
| 30 |
María Gabriela Morales, Daniel Cabrera, Carlos Céspedes, Carlos P. Vio, Yaneisi Vazquez, Enrique Brandan, Claudio Cabello-Verrugio. Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2). Cell and Tissue Research 2013; 353(1): 173 doi: 10.1007/s00441-013-1642-6
|
| 31 |
Ana Cristina Simões e Silva, Aline S Miranda, Natália P Rocha, Antônio L Teixeira. Renin angiotensin system in liver diseases: Friend or foe?. World Journal of Gastroenterology 2017; 23(19): 3396-3406 doi: 10.3748/wjg.v23.i19.3396
|
| 32 |
H.A. Murad, Z.J. Gazzaz, S.S. Ali, M.S. Ibraheem. Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats. Brazilian Journal of Medical and Biological Research 2017; 50(11) doi: 10.1590/1414-431x20176665
|
| 33 |
HAIYANG HUANG, JIE ZHOU, ZHONGLIN CUI, BIAO WANG, YUNWEI HU. Angiotensin II type 1 receptor-associated protein plays a role in regulating the local renin-angiotensin system in HSC-T6 cells. Molecular Medicine Reports 2015; 12(3): 3763 doi: 10.3892/mmr.2015.3849
|
| 34 |
Luciana Mendes Araújo Borém, Daniela Fernanda Freitas, Amanda Souto Machado, Alanna Fernandes Paraíso, Bruna Viana Caldas, João Felício Rodrigues Neto, Juliana Pinto Lima, André Luiz Sena Guimarães, Alfredo Maurício Batista de Paula, Sérgio Henrique Sousa Santos. Angiotensin II type 1 receptor (AT1) blockade by Telmisartan attenuates hepatic steatosis in high-fat fed mice reducing Resistin, TRL4, and Myd88 expression. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00216-w
|
| 35 |
Eylem Taskin, Celal Guven. Renin-Angiotensin System - Past, Present and Future. 2017; doi: 10.5772/65919
|
| 36 |
Lukasz Stawski, Rong Han, Andreea M Bujor, Maria Trojanowska. Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis. Arthritis Research & Therapy 2012; 14(4): R194 doi: 10.1186/ar4028
|
| 37 |
Hong Xu, Fang Yang, Ying Sun, Yuan Yuan, Hua Cheng, Zhongqiu Wei, Shuyu Li, Tan Cheng, Darrell Brann, Ruimin Wang, Oliver Eickelberg. A New Antifibrotic Target of Ac-SDKP: Inhibition of Myofibroblast Differentiation in Rat Lung with Silicosis. PLoS ONE 2012; 7(7): e40301 doi: 10.1371/journal.pone.0040301
|
| 38 |
Megumi Kanasaki, Takako Nagai, Munehiro Kitada, Daisuke Koya, Keizo Kanasaki. Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors. Fibrogenesis & Tissue Repair 2011; 4(1) doi: 10.1186/1755-1536-4-25
|
| 39 |
Raphael Rozenfeld, Achla Gupta, Khatuna Gagnidze, Maribel P Lim, Ivone Gomes, Dinah Lee-Ramos, Natalia Nieto, Lakshmi A Devi. AT1R-CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. The EMBO Journal 2011; 30(12): 2350 doi: 10.1038/emboj.2011.139
|
| 40 |
Michael Trauner, Marco Arrese, Martin Wagner. Fatty liver and lipotoxicity. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2010; 1801(3): 299 doi: 10.1016/j.bbalip.2009.10.007
|
| 41 |
Xiaoping Zhang, Feng Zhang, Desong Kong, Xiafei Wu, Naqi Lian, Li Chen, Yin Lu, Shizhong Zheng. Tetramethylpyrazine inhibits angiotensin II‐induced activation of hepatic stellate cells associated with interference of platelet‐derived growth factor β receptor pathways. The FEBS Journal 2014; 281(12): 2754 doi: 10.1111/febs.12818
|
| 42 |
Brenda de Oliveira da Silva, Letícia Ferrreira Ramos, Karen C. M. Moraes. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis. Cell Biology International 2017; 41(9): 946 doi: 10.1002/cbin.10790
|
| 43 |
Claudio Cabello‐Verrugio, María Gabriela Morales, Juan Carlos Rivera, Daniel Cabrera, Felipe Simon. Renin‐Angiotensin System: An Old Player with Novel Functions in Skeletal Muscle. Medicinal Research Reviews 2015; 35(3): 437 doi: 10.1002/med.21343
|
| 44 |
Guo-wei Wei, Ke-yue Li, Ke-li Tang, Cheng-Xian Shi. Tanshinone IIA alters the transforming growth factor-β1/Smads pathway in angiotensin II-treated rat hepatic stellate cells. Journal of International Medical Research 2020; 48(6): 030006052092635 doi: 10.1177/0300060520926358
|
| 45 |
Aline Silva de Miranda, Ana Cristina Simões e Silva. Angiotensin-(1-7). 2019; : 191 doi: 10.1007/978-3-030-22696-1_12
|
| 46 |
Quandong Hu, Zhenzhen Hu, Qiongfeng Chen, Yonghong Huang, Zi Mao, Fangyun Xu, Xiaoyan Zhou. BML-111 equilibrated ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis to protect hepatic fibrosis in rats. Prostaglandins & Other Lipid Mediators 2017; 131: 75 doi: 10.1016/j.prostaglandins.2017.08.008
|
| 47 |
Bo-nan Zhang, Xin Zhang, Hong Xu, Xue-min Gao, Gui-zhen Zhang, Hui Zhang, Fang Yang. Dynamic Variation of RAS on Silicotic Fibrosis Pathogenesis in Rats. Current Medical Science 2019; 39(4): 551 doi: 10.1007/s11596-019-2073-8
|
| 48 |
Cemal Nuri ERÇİN, Teoman DOĞRU, Gürkan ÇELEBİ, Hasan GÜREL, Halil GENÇ, Erdim SERTOĞLU, Sait BAĞCI. The relationship between blood urea nitrogen levels and metabolic, biochemical, and histopathologic findings of nondiabetic, nonhypertensive patients with nonalcoholic fatty liver disease. TURKISH JOURNAL OF MEDICAL SCIENCES 2016; 46: 985 doi: 10.3906/sag-1502-144
|
| 49 |
Takahiro Kochi, Masahito Shimizu, Daishi Terakura, Atsushi Baba, Tomohiko Ohno, Masaya Kubota, Yohei Shirakami, Hisashi Tsurumi, Takuji Tanaka, Hisataka Moriwaki. Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: Suppressing effects of EGCG on the development of liver lesions. Cancer Letters 2014; 342(1): 60 doi: 10.1016/j.canlet.2013.08.031
|
| 50 |
Takako Nagai, Kyoko Nitta, Megumi Kanasaki, Daisuke Koya, Keizo Kanasaki. The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis. Clinical and Experimental Nephrology 2015; 19(1): 65 doi: 10.1007/s10157-014-1000-3
|
| 51 |
Luciana M. A. Borém, João F. R. Neto, Igor V. Brandi, Deborah F Lelis, Sergio H. S. Santos. The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review. Hypertension Research 2018; 41(6): 394 doi: 10.1038/s41440-018-0040-6
|
| 52 |
Yu Wu, Kun L. Ma, Yang Zhang, Yi Wen, Gui H. Wang, Ze B. Hu, Liang Liu, Jian Lu, Pei P. Chen, Xiong Z. Ruan, Bi C. Liu. Lipid disorder and intrahepatic renin–angiotensin system activation synergistically contribute to non‐alcoholic fatty liver disease. Liver International 2016; 36(10): 1525 doi: 10.1111/liv.13131
|
| 53 |
Li Yao, Yun-Long Zhang, Jue Li, Jing Yu, Yan Peng. Effect of Biejiajian Oral Liquid on the Expression of RAAS in Hepatic Fibrosis Rats. Pharmacology & Pharmacy 2012; 3(03): 322 doi: 10.4236/pp.2012.33043
|
| 54 |
Jack Rychik, Elizabeth Goldmuntz. Invited Commentary: The Hunt for Mechanistic Origins of Liver Fibrosis in the Fontan Circulation. World Journal for Pediatric and Congenital Heart Surgery 2021; 12(2): 173 doi: 10.1177/2150135121989974
|
| 55 |
Ali Fatehi Hassanabad, Anna N. Zarzycki, Kristina Jeon, Jameson A. Dundas, Vishnu Vasanthan, Justin F. Deniset, Paul W. M. Fedak. Prevention of Post-Operative Adhesions: A Comprehensive Review of Present and Emerging Strategies. Biomolecules 2021; 11(7): 1027 doi: 10.3390/biom11071027
|
| 56 |
Tarek M. Mostafa, Gamal A. El-azab, Gamal A. Badra, Alyaa S. Abdelwahed, Abeer A. Elsayed. Effect of Candesartan and Ramipril on Liver Fibrosis in Patients with Chronic Hepatitis C Viral Infection: A Randomized Controlled Prospective Study. Current Therapeutic Research 2021; 95: 100654 doi: 10.1016/j.curtheres.2021.100654
|
| 57 |
Lifang Zou, Xia Yu, Kezhou Cai, Baocai Xu, Conggui Chen, Guiran Xiao. Angiotensin-converting enzyme inhibitory peptide IVGFPAYGH protects against liver injury in mice fed a high‑sodium diet by inhibiting the RAS and remodeling gut microbial communities. International Journal of Biological Macromolecules 2024; 256: 128265 doi: 10.1016/j.ijbiomac.2023.128265
|
| 58 |
Caiping Mao, Rong Liu, Le Bo, Ningjing Chen, Shigang Li, Shuixiu Xia, Jie Chen, Dawei Li, Lubo Zhang, Zhice Xu. High-salt diets during pregnancy affected fetal and offspring renal renin–angiotensin system. Journal of Endocrinology 2013; 218(1): 61 doi: 10.1530/JOE-13-0139
|
| 59 |
Fangyuan Ren, Hongyang Jiang, Lin Shi, Lan Zhang, Xiao Li, Qinkang Lu, Qiang Li. 68Ga-cyc-DX600 PET/CT in ACE2-targeted tumor imaging. European Journal of Nuclear Medicine and Molecular Imaging 2023; 50(7): 2056 doi: 10.1007/s00259-023-06159-7
|
| 60 |
Alessandra Anna Altomare, Gilda Aiello, Jessica Leite Garcia, Giulia Garrone, Beatrice Zoanni, Marina Carini, Giancarlo Aldini, Alfonsina D’Amato. Protein Profiling of a Cellular Model of NAFLD by Advanced Bioanalytical Approaches. International Journal of Molecular Sciences 2022; 23(16): 9025 doi: 10.3390/ijms23169025
|
| 61 |
Rebekah Baskin, Peter P. Sayeski. Angiotensin II mediates cell survival through upregulation and activation of the serum and glucocorticoid inducible kinase 1. Cellular Signalling 2012; 24(2): 435 doi: 10.1016/j.cellsig.2011.09.016
|
| 62 |
Alexandre Maximiliano Trevisan, Bruno Cogliati, Adriana Ribeiro Homem, Thiago Pinheiro Arrais Aloiav, Nelson de Aquino Neto, Jairo Marques Moreira, Leonardo da Cruz Reno, Alexandre Moulin Naumann, Flavio Henrique Ferreira Galvão, Wellington Andraus, Luiz Augusto Carneiro D'Albuquerque. The liver injury following ischemia and reperfusion is worse in experimental knockout heterozygote mouse model for expression of connexin 43. Acta Cirurgica Brasileira 2019; 34(10) doi: 10.1590/s0102-865020190100000003
|
| 63 |
Gaeun Kim, Juyoung Kim, Yoo Li Lim, Moon Young Kim, Soon Koo Baik. Renin–angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review. Hepatology International 2016; 10(5): 819 doi: 10.1007/s12072-016-9705-x
|
| 64 |
Emilie Crouchet, Shen Li, Mozhdeh Sojoodi, Simonetta Bandiera, Naoto Fujiwara, Hussein El Saghire, Shijia Zhu, Tongqi Qian, Fahmida Akter Rasha, Fabio Del Zompo, Stephen C. Barrett, Eugénie Schaeffer, Marine A. Oudot, Clara Ponsolles, Sarah C. Durand, Sarani Ghoshal, Gunisha Arora, Fabio Giannone, Raymond T. Chung, Nevena Slovic, Nicolaas Van Renne, Emanuele Felli, Patrick Pessaux, Joachim Lupberger, Nathalie Pochet, Catherine Schuster, Kenneth K. Tanabe, Yujin Hoshida, Bryan C. Fuchs, Thomas F. Baumert. Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation. JCI Insight 2022; 7(13) doi: 10.1172/jci.insight.159254
|